⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10867541 | 0.62 | TNKS (0.32) | — | |
| SCHEMBL3448355 | 0.58 | — | — | |
| SCHEMBL2927541 | 0.55 | — | — | |
| SCHEMBL12246250 | 0.54 | ALDH1A1 (0.38) | — | |
| SCHEMBL2921630 | 0.54 | — | — | |
| SCHEMBL10101240 | 0.54 | ALDH1A1 (0.36) | — | |
| SCHEMBL11098685 | 0.54 | ADORA2A (0.45) | — | |
| SCHEMBL30315297 | 0.50 | — | — | |
| SCHEMBL20456370 | 0.50 | — | — | |
| SCHEMBL4948959 | 0.49 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103877-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 中生复诺健生物科技(上海)有限公司 | 2026-05-21 | — | — | WO | disclosed |
| EP-4729614-A1 | SYSTEM AND METHOD FOR SEPARATING MRNA | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2026-04-22 | — | — | EP | disclosed |
| CN-120129688-A | Efficient method for preparing highly purified 5' -capped oligonucleotides | 垂林克生物技术有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-119751285-A | Lipid compounds and lipid nanoparticle compositions | 中生复诺健生物科技(上海)有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20250108007-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2025-04-03 | — | — | US | disclosed |
| CN-116829578-B | Polynucleotides encoding interleukin-12 (IL-12) and compositions and methods related thereto | 苏州艾博生物科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119654141-A | Lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-117083291-B | Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2 Delta strain | 苏州艾博生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119432830-A | Systems and methods for isolating mRNA | 苏州艾博生物科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119451976-A | Mutant fragments of VZV glycoprotein E | 苏州艾博生物科技有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-114206827-B | Lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-116064598-A | Nucleic acid vaccine for coronavirus | 苏州艾博生物科技有限公司 | 2023-05-05 | — | — | CN | disclosed |
| US-20230073999-A1 | POLYNUCLEOTIDE AND PHARMACEUTICAL COMPOSITION | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2023-03-09 | — | — | US | disclosed |
| WO-2023277168-A1 | POLYNUCLEOTIDE AND MEDICINAL COMPOSITION | 協和キリン株式会社 | 2023-01-05 | — | — | WO | disclosed |
| EP-4082579-A1 | POLYNUCLEOTIDE AND MEDICINAL COMPOSITION | National University Corporation Tokai National Higher Education and Research System (JP) | 2022-11-02 | — | — | EP | disclosed |
| CN-115176000-A | Polynucleotide and pharmaceutical composition | 国立大学法人东海国立大学机构 | 2022-10-11 | — | — | CN | disclosed |
| CN-114391008-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-114206463-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-114206827-A | Lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20080026381-A1 | Nucleotide analogs | FLUIDIGM CORPORATION | 2008-01-31 | — | — | US | disclosed |